Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Hilleman

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of the American Pharmacists Association : Japha|March 6, 2021
Vitamin D supplements: The pharmacists' perspectiveAshwaq A Awadh, Daniel E Hilleman, Emily Knezevich, et al.
Cardiology Research|March 29, 2017
Aliskiren in Patients Failing to Achieve Blood Pressure Targets With Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor BlockersElizabeth B Hawkins, Hua Ling, Tammy L Burns, et al.
Cardiology Research|March 29, 2017
Reducing Heart Failure Hospital Readmissions: A Systematic Review of Disease Management ProgramsJanardhana Gorthi, Claire B Hunter, Ayran N Mooss, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acidSusan M Schima, Stephanie R Maciejewski, Daniel E Hilleman, et al.
Progress in Cardiovascular Diseases|November 13, 2015
Treatment of Depression in Patients with Concomitant Cardiac DiseaseRobyn M Teply, Kathleen A Packard, Nicole D White, et al.
Pharmacotherapy|October 6, 2004
Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failureThomas L Lenz, Pamela A Foral, Mark A Malesker, et al.
Pharmacotherapy|April 28, 2007
Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratioTammy Burns, Stephanie R Maciejewski, William R Hamilton, et al.
American Heart Journal|December 9, 2003
Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiographyJ Bradley Oldemeyer, W Paul Biddle, Richard L Wurdeman, et al.
Pharmacotherapy|December 24, 2002
Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart diseaseKathleen A Packard, James M Backes, Thomas L Lenz, et al.
Ethnicity & Disease|November 2, 2005
Low high-density lipoprotein cholesterol is associated with impaired endothelial function in Asian IndiansKathleen A Packard, Farhan Majeed, Syed M Mohiuddin, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of the American Pharmacists Association : Japha|March 6, 2021
Vitamin D supplements: The pharmacists' perspectiveAshwaq A Awadh, Daniel E Hilleman, Emily Knezevich, et al.
Cardiology Research|March 29, 2017
Aliskiren in Patients Failing to Achieve Blood Pressure Targets With Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor BlockersElizabeth B Hawkins, Hua Ling, Tammy L Burns, et al.
Cardiology Research|March 29, 2017
Reducing Heart Failure Hospital Readmissions: A Systematic Review of Disease Management ProgramsJanardhana Gorthi, Claire B Hunter, Ayran N Mooss, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acidSusan M Schima, Stephanie R Maciejewski, Daniel E Hilleman, et al.
Progress in Cardiovascular Diseases|November 13, 2015
Treatment of Depression in Patients with Concomitant Cardiac DiseaseRobyn M Teply, Kathleen A Packard, Nicole D White, et al.
Pharmacotherapy|October 6, 2004
Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failureThomas L Lenz, Pamela A Foral, Mark A Malesker, et al.
Pharmacotherapy|April 28, 2007
Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratioTammy Burns, Stephanie R Maciejewski, William R Hamilton, et al.
American Heart Journal|December 9, 2003
Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiographyJ Bradley Oldemeyer, W Paul Biddle, Richard L Wurdeman, et al.
Pharmacotherapy|December 24, 2002
Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart diseaseKathleen A Packard, James M Backes, Thomas L Lenz, et al.
Ethnicity & Disease|November 2, 2005
Low high-density lipoprotein cholesterol is associated with impaired endothelial function in Asian IndiansKathleen A Packard, Farhan Majeed, Syed M Mohiuddin, et al.
Pageof 7